Tag: cancer

The landscape of hypertension management is facing a potential paradigm shift following the presentation of a groundbreaking artificial intelligence study at the ENDO 2026 conference in Chicago, Illinois. Researchers from the Mayo Clinic have unveiled a sophisticated machine learning model designed to identify patients at high risk for primary aldosteronism (PA), a frequently overlooked but…

The Endocrine Society has officially released a comprehensive Scientific Statement that fundamentally redefines the clinical approach to obesity, moving the focus away from the number on the scale and toward the broader systemic health benefits of medical intervention. Published in the journal Endocrine Reviews, the statement emphasizes that the primary goal of obesity treatment is…

The clinical management of pediatric pituitary tumors (PPTs) represents one of the most complex challenges in modern endocrinology, not merely because of the rarity of the condition, but due to the fraught period when a young patient must transition from the protective environment of pediatric care to the more autonomous world of adult medicine. This…

Moonwalk Biosciences, a biotechnology firm at the forefront of epigenetic and RNA interference (RNAi) research, has successfully closed an oversubscribed $70 million Series B financing round. The capital injection is earmarked for the development of a new class of medicines that target adipose tissue directly, offering a specialized alternative to the current landscape of incretin-based…

The landscape of endocrine and renal pharmacology has witnessed a transformative week with two major clinical developments that promise to reshape the standard of care for patients with chronic kidney disease (CKD) and severe hypertriglyceridemia (sHTG). Bayer’s KERENDIA (finerenone) has secured a landmark FDA approval for adult patients with CKD associated with type 1 diabetes…

The United States Senate Committee on Health, Education, Labor, and Pensions (HELP) has reached a critical milestone in the ongoing effort to address the escalating costs of diabetes care by passing the INSULIN Act. This bipartisan legislation, spearheaded by Senators Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA), represents a…

The Endocrine Society has officially named 13 distinguished endocrinologists as the recipients of its 2027 Laureate Awards, marking the highest honors bestowed within the field of hormone health and metabolic research. Established in 1944, these prestigious accolades recognize individuals who have demonstrated a lifetime of dedication to scientific discovery, clinical innovation, and the advancement of…

In a significant week for the pharmaceutical industry and patient advocacy groups, the U.S. Food and Drug Administration (FDA) has issued a series of landmark approvals and regulatory designations aimed at addressing severe unmet medical needs. These developments span from the first-ever treatment for a rare and devastating genetic deficiency to advancements in the management…

The clinical management of pheochromocytomas and paragangliomas (PPGLs) has long been one of the most daunting challenges in the field of endocrinology and oncology. These rare neuroendocrine tumors, which arise from chromaffin cells of the adrenal medulla or extra-adrenal sympathetic and parasympathetic ganglia, present a unique paradox to clinicians: while approximately 75% of these tumors…

The modern endocrinology practice operates at the intersection of chronic disease management, complex laboratory analysis, and rapid technological advancement. For clinicians in this specialty, the Electronic Health Record (EHR) has evolved far beyond its initial conception as a digital repository for patient charts. Today, these platforms serve as the central nervous system of the clinic,…